| |
|
|
|
|
|
|
|||
|
Prepublished online as a Blood First Edition Paper on August 15, 2002; DOI 10.1182/blood-2002-03-0894.
Submitted March 21, 2002
PROCREA BioSciences, Montreal, PQ, Canada; Department of Microbiology and Immunology, McGill University, Montreal, PQ, Canada * Corresponding author; email: asteff{at}procrea.qc.ca.
A major drawback of the current anti-neoplastic treatments is their lack of specificity towards cancer cells, as they are most often cytotoxic to normal cells, thus creating related side effects. Hence, the identification of new apoptosis-inducing agents, specifically targeting malignant cells while sparing their normal counterparts, is of crucial interest. We show here that monoglycerides, a family of lipids consisting of a single fatty acid attached to a glycerol backbone, induce cell death in several human leukemic cell lines. Importantly, treatment of primary leukemic cells, obtained from B-cell chronic lymphocytic leukemia patients, resulted in rapid apoptosis. In striking contrast, resting or activated human peripheral blood mononuclear cells from healthy individuals were resistant to the same treatment. Therefore, these compounds could represent potential anti-leukemic drugs or could allow for the design of novel therapeutic agents applied to leukemia.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||